Supramolecular Delivery Systems for NonPlatinum Metal-Based Anticancer Drugs

被引:10
|
作者
Ringhieri, Paola [1 ]
Morelli, Giancarlo [1 ]
Accardo, Antonella [1 ]
机构
[1] Univ Naples Federico II, Dept Pharm, Interuniv Res Ctr Bioact Peptides CIRPeB, CIRCMSB, Via Mezzocannone 16, I-80134 Naples, Italy
关键词
metal-based drugs; delivery systems; liposomes; micelles; supramolecular aggregates; polymeric particles; INTERCALATIVE DNA-BINDING; NUCLEIC-ACID BINDING; ANTITUMOR-ACTIVITY; MICELLIZATION BEHAVIOR; COPPER-COMPLEXES; SURFACTANT-COBALT(III) COMPLEXES; PLATINUM COMPLEXES; COPOLYMER MICELLES; CRYSTAL-STRUCTURE; DNA/RNA BINDING;
D O I
10.1615/CritRevTherDrugCarrierSyst.2017016936
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stimulated by the enormous success of the inorganic complex cisplatin in tumor treatment, interest in metal complexes has recently grown. Within cells, metal complexes can participate in reactions that are not possible with conventional organic substances, and most of them have promising efficacy as anticancer drugs. However, to be effective in vivo metal complexes need adequate delivery systems able to increase their water solubility, the in vivo bioavailability, and the safe delivery to target organs. The present review reports on the state of the art of these new, nonplatinum, anticancer metallodrugs delivered by nanosized vehicles. The development of complexes of ruthenium, gold, cobalt, copper, gallium, and others that show promising antitumor efficacy is reported, and we emphasize the different approaches in the individuation of the most appropriate delivery system for each of them.
引用
收藏
页码:149 / 183
页数:35
相关论文
共 50 条
  • [1] Novel metal-based anticancer drugs: a new challenge in drug delivery
    Laine, Anne-Laure
    Passirani, Catherine
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (04) : 420 - 426
  • [2] Anionic PAMAM dendrimers as drug delivery vehicles for transition metal-based anticancer drugs
    Pisani, Michelle J.
    Wheate, Nial J.
    Keene, F. Richard
    Aldrich-Wright, Janice R.
    Collins, J. Grant
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2009, 103 (03) : 373 - 380
  • [3] Gold complexes as prospective metal-based anticancer drugs
    Milacic, V.
    Fregona, D.
    Dou, Q. P.
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2008, 23 (01) : 101 - 108
  • [4] Polymeric Prodrugs Containing Metal-Based Anticancer Drugs
    B. A. Aderibigbe
    [J]. Journal of Inorganic and Organometallic Polymers and Materials, 2015, 25 : 339 - 353
  • [5] Polymeric Prodrugs Containing Metal-Based Anticancer Drugs
    Aderibigbe, B. A.
    [J]. JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS, 2015, 25 (03) : 339 - 353
  • [6] Transition Metal-Based Prodrugs for Anticancer Drug Delivery
    Phillips, Ana M. F.
    Pombeiro, Armando J. L.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2019, 26 (41) : 7476 - 7519
  • [7] Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents
    Gou, Yi
    Huang, GuoJin
    Li, Jinlong
    Yang, Feng
    Liang, Hong
    [J]. COORDINATION CHEMISTRY REVIEWS, 2021, 441
  • [8] Supramolecular metal-based nanoparticles for drug delivery and cancer therapy
    Jiang, Xiaomin
    He, Chunbai
    Lin, Wenbin
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2021, 61 : 143 - 153
  • [9] A New Look into the Mode of Action of Metal-Based Anticancer Drugs
    Marques, M. Paula M.
    de Carvalho, Ana L. M. Batista
    Mamede, Adriana P.
    Dopplapudi, Asha
    Rudic, Svemir
    Tyagi, Madhusudan
    Sakai, Victoria Garcia
    Batista de Carvalho, Luis A. E.
    [J]. MOLECULES, 2020, 25 (02):
  • [10] Electron-transfer activated metal-based anticancer drugs
    Reisner, Erwin
    Arion, Vladimir B.
    Keppler, Bernhard K.
    Pombeiro, Armando J. L.
    [J]. INORGANICA CHIMICA ACTA, 2008, 361 (06) : 1569 - 1583